Clinical Trials Directory

Trials / Completed

CompletedNCT02705326

Evaluating the Efficacy of Opti-Speech for Speech Treatment

Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Vulintus, Inc. · Industry
Sex
All
Age
12 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if feedback from a three-dimensional real-time visualization of the tongue, a program called Opti-Speech, can be used to improve speech.

Detailed description

Participants will be asked to complete the Goldman Fristoe Test of Articulation along with several other assessment tests. Then speech treatment, guided by Opti-Speech, will be provided to the participant for up to 10 treatment sessions. The participant will be asked to come back after the final treatment for a 2-month follow-up assessment.

Conditions

Interventions

TypeNameDescription
DEVICEOpti-SpeechUses visual feedback of the tongue's motion to guide speech sound production

Timeline

Start date
2016-01-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2016-03-10
Last updated
2018-12-31

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02705326. Inclusion in this directory is not an endorsement.